Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma

This study has been completed.
University of Maryland Greenebaum Cancer Center
Information provided by:
University of Maryland Identifier:
First received: November 1, 1999
Last updated: September 23, 2009
Last verified: September 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2002
  Primary Completion Date: December 2002 (Final data collection date for primary outcome measure)